Local C-Path leads project for drug-firm info sharing
By Dale Quinn
ARIZONA DAILY STAR
For the first time, 17 major pharmaceutical companies have agreed to share information to fight major diseases such as Parkinson’s and Alzheimer’s, said the president of the Tucson-based non-profit institute that’s leading a drug-safety consortium.
The companies still need to hammer out the legal details of such an agreement, and that could take until the fall, said Dr. Raymond Woosley, the president and CEO of the Critical Path Institute, known as C-Path.
“One of the reasons drugs have been failing, even though they’ve had millions of dollars of lab work … (is that) most of the time we don’t understand the diseases well enough,” Woosley said.